A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)

BACKGROUND: Lung adenocarcinoma (LUAD) is one of the most common types in the world with a high mortality rate. Despite advances in treatment strategies, the overall survival (OS) remains short. Our study aims to establish a reliable prognostic signature closely related to the survival of LUAD patie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Cell Int
Egile Nagusiak: Al-Dherasi, Aisha, Huang, Qi-Tian, Liao, Yuwei, Al-Mosaib, Sultan, Hua, Rulin, Wang, Yichen, Yu, Ying, Zhang, Yu, Zhang, Xuehong, Huang, Chao, Mousa, Haithm, Ge, Dongcen, Sufiyan, Sufiyan, Bai, Wanting, Liu, Ruimei, Shao, Yanyan, Li, Yulong, Zhang, Jingkai, Shi, Leming, Lv, Dekang, Li, Zhiguang, Liu, Quentin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Primary Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183047/
https://ncbi.nlm.nih.gov/pubmed/34092242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01975-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak